ALS, or amyotrophic lateral sclerosis, is a disease that affects the nervous system. It causes muscle weakness and impacts physical function. It is often called Lou Gehrig’s disease, after the famous baseball player who was diagnosed with it. ALS is a motor neuron disease that causes nerve cells to gradually break down and die. While a small number of cases are inherited, doctors do not know why ALS occurs. Symptoms usually begin with muscle twitching and weakness in an arm or leg and sometimes slurred speech. It gradually affects the ability to control muscles needed to speak, eat, breathe and move. There is no cure, and ultimately it is fatal.
During the past 40 years, the UAB Neuromuscular Disease Service has grown into an internationally recognized center for clinical care, diagnostic clinical neurophysiology, and diagnostic muscle and nerve histopathology. As the only dedicated tertiary care neuromuscular center in Alabama, our board-certified neurologists with subspecialty expertise provide comprehensive care with the most current medical techniques for a broad array of diseases and conditions.
Thanks to UAB’s strong clinical and basic research programs, you can be assured that we remain at the pioneering edge of medical discoveries, which could lead to opportunities for you to participate in studies and receive medications and treatments not available at most other health care centers.
We excel at the diagnosis and treatment of neuromuscular disorders. Our specialists have authored major textbooks on electromyography and evoked potential. Moreover, our dedicated diagnostic laboratory and biopsy suite helps ensure the most comprehensive assessment and pathologic diagnosis of peripheral nervous system disorders in the Southeast.
Care Providers
Resources
- UAB Division of Memory Disorders and Behavioral Neurology
- Amyotrophic Lateral Sclerosis (ALS) Fact Sheet
- Amyotrophic Lateral Sclerosis
Related Specialties
Clinical Trials
Speak to your physician about your options and browse the link below for more information
Latest News
View All News-
UAB adds new MEG technology to enhance research and clinical care for epilepsy and other brain diseases
November 21, 2024
-
Human proteins identified that explain inter-individual differences in functional brain connectivity
October 31, 2024
-
UAB and ADPH implement new system aimed at improving Alabama’s stroke response
October 23, 2024
-
Right-side deep brain stimulation may preserve verbal fluency in Parkinson’s patients
September 26, 2024
-
Blazer Bridge Fund continues encouraging innovative discoveries; announces 2024 winners
September 20, 2024